Network News

MANNHEIM, Germany, May 13, 2025 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced its decision to file an application for opening of insolvency proceedings with the local court of Mannheim in Germany. As previously reported, Affimed N.V. (the “Company”) […]

VDI Guideline 5708 “Bioprinting, methods and definitions”: What sounds technical and sober at first glance is an important step forward in the future field of 3D bioprinting. The guideline was developed under the leadership of Dr. Hanna Hartmann from the NMI Natural and Medical Sciences Institute in Reutlingen as chairwoman and Prof. Dr. Jürgen Groll […]

Dr Dr Varun Venkataramani and Dr Moritz Mall share the 100,000-euro Hella Bühler Prize Dr Dr Varun Venkataramani and Dr Moritz Mall have been awarded this year’s Hella Bühler Prize for their outstanding research on the interaction between nerve and tumor cells and on tumor plasticity. The award granted by Heidelberg University goes to young […]

At the request of Heidelberg University Hospital, the Ministry of Social Affairs, Health and Integration has confirmed that the merger of the two university hospitals in Heidelberg and Mannheim is deemed necessary to improve hospital care and that the merger does not conflict with any other competition law regulations. Press release from the Ministry of […]

The partnership combines VERAXA’s proprietary ADC technology with OmniAb’s antibody discovery technology for novel therapies targeting solid tumors. ZURICH, SWITZERLAND, May 5, 2025 — VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), announced today a co-discovery alliance with OmniAb, Inc. (NASDAQ: […]

Professor Dr. Gerd Auffarth continues to be one of the world’s leading ophthalmologists, according to “The Ophthalmologist”. The journal has now published its “Power List 2025” of the most influential representatives of the field. The Medical Director of the Eye Clinic at Heidelberg University Hospital (UKHD) has now been named on the list for the […]

The proposed business combination would create a publicly traded, clinical-stage biopharmaceutical company focused on the development of a comprehensive pipeline of next-generation cancer therapies. ZURICH, SWITZERLAND, and BROOKLYN, NEW YORK, USA, April 23, 2025 — VERAXA Biotech AG(“VERAXA” or the “Company”), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands […]

HEIDELBERG, Germany, April 15, 2025 – NEC Laboratories Europe and Data-Driven.AI are working together to enhance medical laboratory diagnosis and increase the effectiveness of preventive health measures and early clinical intervention to improve the well-being of patients. If detected early, many illnesses and diseases can be managed or resolved without serious complications. However, by the time recognizable symptoms present themselves, […]

From April 28 to May 24, you can once again buy and give flower creations throughout Germany for the benefit of children and young people with cancer. With its campaign “Blumen schenken. Hoffnung spenden.” (Give flowers. Spread hope.) the Hopp Children’s Cancer Center Heidelberg (KiTZ) wants to draw attention to the urgently needed research for […]